NCT00666809

Vardenafil in Tinnitus

Evaluation of Vardenafil for the Treatment of Subjective Tinnitus: A Controlled Pilot Study

• Status: Completed
• Phase: Phase 2
• Study type: Interventional
• Enrollment: 43 (actual)
• Sponsor: Bayer · Industry
• Sex: All
• Age: 18 Years – 64 Years
• Healthy volunteers: Not accepted

Summary

There is incidental evidence (casuistic findings) that the treatment with vardenafil of male patients suffering from erectile dysfunction and comorbid tinnitus experienced an improvement of their tinnitus. Randomized, parallel-group, double-blind, placebo-controlled trial over 16 weeks (12 weeks of treatment + 4 weeks follow-up) with 10 mg vardenafil BID p.o. in men and women with chronic tinnitus.

Conditions

• Tinnitus

Interventions

Type	Name	Description
DRUG	Levitra (Vardenafil, BAY38-9456)	Vardenafil 10 mg BID p.o. for 12 weeks + 4 weeks follow-up
DRUG	Placebo	Placebo BID p.o. for 12 weeks + 4 weeks follow-up

Timeline

• Start date: 2006-10-01
• Completion: 2007-05-01
• First posted: 2008-04-25
• Last updated: 2014-12-09

Locations

1 site across 1 country: Germany